US drug regulator delays Novavax Covid vaccine approval

The US drug regulator has missed a deadline for granting full approval to Novavax's Covid-19 vaccine, the company said Wednesday, amid major shakeups at health agencies under President Donald Trump. In a document sent to the financial markets regulator and seen by AFP, US drugmaker Novavax said it was still awaiting a response from the [...]The post US drug regulator delays Novavax Covid vaccine approval appeared first on The Guardian Nigeria News - Nigeria and World News.

Read More